However, X‐irradiated tumours, though smaller, showed higher expression of lymphatic (Lyve1) and vascular markers (CD31), indicating a more aggressive molecular profile than P‐irradiated tumours (Figure 2F–I). The gene discussed is LYVE1; the disease is neoplasm.